X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (7296) 7296
Book Chapter (24) 24
Dissertation (24) 24
Publication (5) 5
Conference Proceeding (4) 4
Magazine Article (3) 3
Newspaper Article (3) 3
Web Resource (3) 3
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
voriconazole (6546) 6546
humans (4580) 4580
male (2362) 2362
antifungal agents - therapeutic use (2271) 2271
microbiology (1973) 1973
female (1846) 1846
pharmacology & pharmacy (1635) 1635
antifungal agents - pharmacology (1598) 1598
infectious diseases (1592) 1592
middle aged (1472) 1472
adult (1365) 1365
fluconazole (1358) 1358
itraconazole (1345) 1345
triazoles - therapeutic use (1342) 1342
amphotericin-b (1223) 1223
pyrimidines - therapeutic use (1160) 1160
microbial sensitivity tests (1078) 1078
antifungal agents (1060) 1060
mycology (990) 990
aspergillosis (953) 953
aged (952) 952
antifungal agents - administration & dosage (952) 952
triazoles - pharmacology (910) 910
posaconazole (827) 827
treatment outcome (817) 817
amphotericin b (814) 814
infections (789) 789
aspergillosis - drug therapy (764) 764
caspofungin (756) 756
pyrimidines - pharmacology (711) 711
mycoses (690) 690
pharmacokinetics (690) 690
therapy (656) 656
invasive aspergillosis (655) 655
mycoses - drug therapy (626) 626
epidemiology (613) 613
triazoles - administration & dosage (602) 602
animals (596) 596
health aspects (590) 590
susceptibility (577) 577
infection (570) 570
adolescent (569) 569
antifungal agents - adverse effects (561) 561
immunology (552) 552
transplantation (551) 551
aspergillus (549) 549
diagnosis (537) 537
amphotericin b - therapeutic use (531) 531
fungal-infections (521) 521
fungi (514) 514
immunocompromised host (510) 510
drug resistance, fungal (508) 508
pyrimidines - administration & dosage (507) 507
antifungal agents - pharmacokinetics (494) 494
amphotericin b - pharmacology (459) 459
voriconazole - therapeutic use (459) 459
safety (455) 455
child (450) 450
retrospective studies (450) 450
young adult (447) 447
candida - drug effects (436) 436
fluconazole - pharmacology (434) 434
risk factors (431) 431
efficacy (430) 430
dermatology (422) 422
lipopeptides (417) 417
care and treatment (416) 416
mycoses - microbiology (404) 404
ophthalmology (392) 392
triazoles - adverse effects (390) 390
drug therapy, combination (387) 387
aspergillosis - microbiology (384) 384
fungal infections (383) 383
echinocandins (377) 377
itraconazole - pharmacology (375) 375
analysis (357) 357
mortality (356) 356
resistance (355) 355
invasive fungal-infections (352) 352
in-vitro (345) 345
liposomal amphotericin-b (344) 344
triazoles - pharmacokinetics (339) 339
candida (338) 338
surgery (333) 333
pyrimidines - adverse effects (331) 331
patients (326) 326
management (320) 320
drug interactions (310) 310
keratitis (310) 310
candidiasis - drug therapy (307) 307
triazoles (299) 299
veterinary sciences (297) 297
research (296) 296
aged, 80 and over (292) 292
aspergillus fumigatus - drug effects (291) 291
internal medicine (290) 290
hematology (289) 289
voriconazole - pharmacology (287) 287
antifungal susceptibility (284) 284
oncology (283) 283
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6793) 6793
Spanish (202) 202
German (190) 190
French (177) 177
Japanese (115) 115
Portuguese (56) 56
Turkish (32) 32
Chinese (27) 27
Korean (26) 26
Italian (18) 18
Russian (13) 13
Polish (9) 9
Czech (5) 5
Hungarian (4) 4
Danish (2) 2
Dutch (2) 2
Icelandic (2) 2
Slovenian (2) 2
Bulgarian (1) 1
Estonian (1) 1
Hebrew (1) 1
Persian (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
British journal of clinical pharmacology, ISSN 0306-5251, 2018, Volume 84, Issue 7, pp. 1587 - 1597
Aims The aims of the present study were to characterize the pharmacokinetics of voriconazole in renal transplant recipients and to identify factors... 
CYP2C19 polymorphism | voriconazole | dosing simulation | renal transplant recipients | population pharmacokinetics | ADULT PATIENTS | PRACTICE GUIDELINES | 2016 UPDATE | INVASIVE FUNGAL-INFECTIONS | INTRAVENOUS VORICONAZOLE | DISEASES SOCIETY | DOSAGE REGIMENS | SERUM CONCENTRATIONS | PHARMACOLOGY & PHARMACY | STEM-CELL TRANSPLANTATION | TROUGH LEVELS | Antifungal Agents - adverse effects | Biological Variation, Population - physiology | Body Weight | Prospective Studies | Humans | Middle Aged | Biological Availability | Male | Transplant Recipients | Intestinal Absorption | Dose-Response Relationship, Drug | Young Adult | Voriconazole - administration & dosage | Time Factors | Invasive Fungal Infections - drug therapy | Antifungal Agents - pharmacokinetics | Adult | Female | Immunosuppressive Agents - administration & dosage | Voriconazole - adverse effects | Administration, Oral | Graft Rejection - prevention & control | Postoperative Period | Cytochrome P-450 CYP2C19 - genetics | Genotype | Voriconazole - pharmacokinetics | Models, Biological | Cytochrome P-450 CYP2C19 - metabolism | Immunosuppressive Agents - adverse effects | Polymorphism, Single Nucleotide | Graft Rejection - immunology | Antifungal Agents - administration & dosage | Invasive Fungal Infections - immunology | Kidney Transplantation - adverse effects | Kidneys | Analysis | Cytochrome P-450 | Mycoses | Organ transplant recipients | Genetic aspects | Transplantation | Original
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2016, Volume 387, Issue 10020, pp. 760 - 769
Journal Article
Drug resistance updates, ISSN 1368-7646, 2014, Volume 17, Issue 3, pp. 37 - 50
Journal Article
Journal Article